Market Overview
The European CGM market encompasses devices and consumables that continuously track glucose levels in patients with diabetes, transmitting data to smartphones or dedicated receivers. Regional market size estimates range from approximately $2.04 billion to $3.10 billion across various industry analyses, reflecting differing methodologies and scope definitions. The sector covers system components including sensors, transmitters, and displays, serving both Type 1 and Type 2 diabetes populations through hospitals, clinics, and home healthcare settings.
- •Sensors are the dominant consumable segment, driven by regular replacement cycles
- •Home healthcare integration is expanding CGM adoption beyond clinical environments
- •National diabetes expenditures across European countries heavily support market growth
Growth Drivers
Rising diabetes prevalence across Europe is the primary catalyst, alongside expanding reimbursement frameworks that make CGM systems more accessible to patients. Technological innovation in minimally invasive sensors, smartphone integration, and remote patient monitoring capabilities continues to accelerate adoption rates. The expansion of telemedicine services and digital health infrastructure has further boosted demand for connected glucose monitoring solutions.
- •Increasing diabetes incidence rates across European populations
- •Advancements in minimally invasive sensor technologies
- •Expansion of telemedicine and remote patient monitoring infrastructure
Segmentation and Regional Analysis
The market is segmented by components (sensors, transmitters, displays), end-users (hospitals, clinics, home care), and diabetes type (Type 1, Type 2). Germany commands the largest regional market share, followed by the United Kingdom and France, where high adoption rates and strong healthcare infrastructure support market expansion. Consumable sensor replacements represent a significant and recurring revenue stream due to their limited lifespan.
- •Germany leads European CGM market share, followed by the UK and France
- •Consumable sensors drive segment dominance through regular replacement demand
- •Both Type 1 and Type 2 diabetes indications represent major end-user categories
Trends and Outlook
What are the recent trends and outlook?
Smart sensor miniaturization and enhanced connectivity with mobile health platforms represent key emerging trends shaping the market trajectory. Integration of CGM data into broader digital health ecosystems and the shift toward personalized diabetes management are driving product innovation. Projections through 2035 indicate sustained double-digit growth as technology improves, costs decline, and healthcare systems increasingly prioritize preventive and remote monitoring solutions.
- •Smart sensor miniaturization and improved patient comfort are advancing product development
- •Remote patient monitoring and data integration with digital health platforms are expanding
- •Long-term outlook through 2035 suggests continued double-digit market expansion
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.